Health Without Borders: Innovation and Capital at the Frontier
summary
Panel argues that global health investment delivers both impact and returns: the fund cited registers 15 new products, doubles investor capital, and scales a cholera vaccine to 230 million doses. Current Ebola response in DRC exposes surveillance gaps; teams deploy BSL3 mobile labs on wheels and push AI to fuse human, animal, and environmental data under One Health. Africa’s genomic richness — 70% genetic diversity — plus startups like InstaDeep, hearX and Yemaachi enable real leapfrogging toward home‑based, AI prevention.
AI-written summary · about
chapters (10)
- 0:00Global health investment origins
- 1:26Changed world new opportunities
- 2:47Ebola outbreak AI role
- 5:17Medicine 3.0 health innovation
- 9:06Global health partnerships
- 13:58AI leapfrogging in health
- 16:27Key takeaways challenges
- 17:51One Health systems
- 18:36Health planetary diagnostic
- 23:52AI wisdom systemic reorientation
related talks
47mLeveraging AI for Global Health
16mHow Biology Benefits from Technological Discoveries
37mAI for Good- Then and Now
21mShaping the future of health: Boehringer Ingelheim's Data & AI Journey
24mAI in Action: Meet the startups, investors and thought leaders shaping Africa’s future
19mTomorrow's biggest growth opportunities
16mDigital Health 2026: Investments, Innovations, Impulses for Care
01h 00mKeynote Panel: AI in Healthcare